Search research articles
Contact Us
Filters
Showing results (1-10 of 19) with videos related to
Page
of 2
Sort By:
The Journal of Clinical Endocrinology and Metabolism
|
August 1, 1978
Metabolic clearance and production rates of 3,3',5-triiodothyronine in hyperthyroid, euthyroid, and hypothyroid subjects
R C Smallridge, L Wartofsky, R E Desjardins, et al.
The Pediatric Infectious Disease Journal
|
October 1, 1987
Safety profile of cefixime
F P Tally, R E Desjardins, E F McCarthy, et al.
Experimental Parasitology
|
June 1, 1988
Plasmodium falciparum: cloning by single-erythrocyte micromanipulation and heterogeneity in vitro
A M Oduola, N F Weatherly, J H Bowdre, et al.
Antimicrobial Agents and Chemotherapy
|
December 1, 1979
Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique
R E Desjardins, C J Canfield, J D Haynes, et al.
Antimicrobial Agents and Chemotherapy
|
April 1, 1985
In vitro activities of and mechanisms of resistance to antifol antimalarial drugs
W K Milhous, N F Weatherly, J H Bowdre, et al.
Lancet (London, England)
|
December 5, 1987
Reduced in-vitro susceptibility to mefloquine in West African isolates of Plasmodium falciparum
A M Oduola, W K Milhous, L A Salako, et al.
Clinical Pharmacology and Therapeutics
|
April 1, 1981
The method of separate exponentials: a simple aid to devising intravenous drug-loading regimens
D G Shand, R E Desjardins, T D Bjornsson, et al.
Antimicrobial Agents and Chemotherapy
|
August 1, 1980
Activity of 2-acetylpyridine thiosemicarbazones against Trypanosoma rhodesiense in vitro
R A Casero, D L Klayman, G E Childs, et al.
The American Journal of Tropical Medicine and Hygiene
|
March 1, 1985
Use of non-human plasma for in vitro cultivation and antimalarial drug susceptibility testing of Plasmodium falciparum
A M Oduola, B M Alexander, N F Weatherly, et al.
Experimental Parasitology
|
December 1, 1988
Plasmodium falciparum: induction of resistance to mefloquine in cloned strains by continuous drug exposure in vitro
A M Oduola, W K Milhous, N F Weatherly, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 19) with videos related to
Sort By:
Page
of 2
The Journal of Clinical Endocrinology and Metabolism
|
August 1, 1978
Metabolic clearance and production rates of 3,3',5-triiodothyronine in hyperthyroid, euthyroid, and hypothyroid subjects
R C Smallridge, L Wartofsky, R E Desjardins, et al.
The Pediatric Infectious Disease Journal
|
October 1, 1987
Safety profile of cefixime
F P Tally, R E Desjardins, E F McCarthy, et al.
Experimental Parasitology
|
June 1, 1988
Plasmodium falciparum: cloning by single-erythrocyte micromanipulation and heterogeneity in vitro
A M Oduola, N F Weatherly, J H Bowdre, et al.
Antimicrobial Agents and Chemotherapy
|
December 1, 1979
Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique
R E Desjardins, C J Canfield, J D Haynes, et al.
Antimicrobial Agents and Chemotherapy
|
April 1, 1985
In vitro activities of and mechanisms of resistance to antifol antimalarial drugs
W K Milhous, N F Weatherly, J H Bowdre, et al.
Lancet (London, England)
|
December 5, 1987
Reduced in-vitro susceptibility to mefloquine in West African isolates of Plasmodium falciparum
A M Oduola, W K Milhous, L A Salako, et al.
Clinical Pharmacology and Therapeutics
|
April 1, 1981
The method of separate exponentials: a simple aid to devising intravenous drug-loading regimens
D G Shand, R E Desjardins, T D Bjornsson, et al.
Antimicrobial Agents and Chemotherapy
|
August 1, 1980
Activity of 2-acetylpyridine thiosemicarbazones against Trypanosoma rhodesiense in vitro
R A Casero, D L Klayman, G E Childs, et al.
The American Journal of Tropical Medicine and Hygiene
|
March 1, 1985
Use of non-human plasma for in vitro cultivation and antimalarial drug susceptibility testing of Plasmodium falciparum
A M Oduola, B M Alexander, N F Weatherly, et al.
Experimental Parasitology
|
December 1, 1988
Plasmodium falciparum: induction of resistance to mefloquine in cloned strains by continuous drug exposure in vitro
A M Oduola, W K Milhous, N F Weatherly, et al.
Page
of 2